Increased systemic inflammation is a risk factor for COPD exacerbations
Groenewegen, Karin H, Postma, Dirkje S, Hop, Wim C J, Wielders, Pascal L M L, Schlösser, Noel J J, Wouters, Emiel F M
Published in Chest (01.02.2008)
Published in Chest (01.02.2008)
Get more information
Journal Article
Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial
Maltais, Francois, Schenkenberger, Isabelle, Wielders, Pascal L. M. L., Ortiz de Saracho, Juan, Chinsky, Kenneth, Watkins, Michael, Millar, Valerie, Crim, Courtney
Published in Therapeutic advances in respiratory disease (2020)
Published in Therapeutic advances in respiratory disease (2020)
Get full text
Journal Article
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial
Lazaar, Aili L, Miller, Bruce E, Donald, Alison C, Keeley, Thomas, Ambery, Claire, Russell, John, Watz, Henrik, Tal-Singer, Ruth
Published in Respiratory research (12.06.2020)
Published in Respiratory research (12.06.2020)
Get full text
Journal Article
Effect of once-daily fluticasone furoate/vilanterol vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial
Francois Maltais, Isabelle Schenkenberger, Pascal L. M. L. Wielders, Juan Ortiz de Saracho, Kenneth Chinsky, Michael Watkins, Valerie Millar, Courtney Crim
Published in Therapeutic advances in respiratory disease (01.10.2020)
Published in Therapeutic advances in respiratory disease (01.10.2020)
Get full text
Journal Article